Revolution Medicines, Inc. (RVMD) Operating margin 2018–2023
Revolution Medicines, Inc. (RVMD) operating margin by fiscal year — reported operating income divided by reported revenue.
-4207.1%FY2023 · since FY2018: -200.0% → -4207.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -4207.1% | -3477.1 pp |
| FY2022 | -730.0% | -90.3 pp |
| FY2021 | -639.7% | -382.2 pp |
| FY2020 | -257.5% | -149.4 pp |
| FY2019 | -108.2% | +91.8 pp |
| FY2018 | -200.0% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More RVMD financial trends
RVMD RevenueRVMD Net incomeRVMD Net marginRVMD Gross profitRVMD Gross marginRVMD Operating incomeRVMD Operating cash flowRVMD Free cash flowRVMD Capital expendituresRVMD Return on equityRVMD Stock buybacksRVMD Dividends paidRVMD Total assetsRVMD Total liabilitiesRVMD Shareholders’ equityRVMD overview →